| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |